An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...
A recent double-blinded, peer-reviewed analysis published in Cancer Lettersrevealed that the experimental test correctly identified 71% of pancreatic cancer samples in the lab compared to only 44% ...
Blood tests like these also don’t mean you can ... particularly for cancers like pancreatic cancer — it’s a very deadly cancer. It’s one we don’t have a screening for.” ...
During January 2025, the registered number of shares and votes in Immunovia AB (publ) ("Immunovia") has increased due exercise of warrants of series TO 2. As of 31 January 2025, the registered number ...